NCT00219089View on ClinicalTrials.gov

A Clinical Study to Evaluate the Safety and Efficacy of Aliskiren Alone and in Combination With Ramipril in Hypertensive, Diabetic Patients.

PHASE3CompletedINTERVENTIONAL
Enrollment

839

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
Hypertension, Diabetes Mellitus
Interventions
DRUG

aliskiren

Trial Locations (2)

07936

Novartis Pharmaceuticals, East Hanover

Unknown

Investigative Centers

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY